Sherrod Brown said "Amendment No. 37 offered by Mr. Brown of Ohio: Insert before the short title the following title: TITLE IX--ADDITIONAL GENERAL PROVISIONS Sec. 901. None of the amounts made available in this Act for the Food and Drug Administration may be expended to approve any application for a new drug submitted by an entity that does not agree to publicly disclose, on a quarterly basis during the patent life of the drug, the average price charged by the manufacturer for the most common dosage of the drug (expressed as total revenues divided by total units sold) in each country that is a member of the Organisation for Economic Co-operation and Development." @ PoliticalQuotes.com

On the recordJuly 11, 2000

Amendment No. 37 offered by Mr. Brown of Ohio: Insert before the short title the following title: TITLE IX--ADDITIONAL GENERAL PROVISIONS Sec. 901. None of the amounts made available in this Act for the Food and Drug Administration may be expended to approve any application for a new drug submitted by an entity that does not agree to publicly disclose, on a quarterly basis during the patent life of the drug, the average price charged by the manufacturer for the most common dosage of the drug (expressed as total revenues divided by total units sold) in each country that is a member of the Organisation for Economic Co-operation and Development.

Said by

Sherrod Brown

Democratic · Ohio

Source

govinfo.gov

Editor's note · Context

Proposing an amendment related to drug pricing transparency during a legislative session.

Share on X Share on Facebook Email this quote